Contraceptive efficacy, compliance and beyond:: Factors related to satisfaction with once-weekly transdermal compared with oral contraception

被引:58
作者
Urdl, W
Apter, D
Alperstein, A
Koll, P
Schönian, S
Bringer, J
Fisherg, AC
Preik, M [1 ]
机构
[1] Janssen Cilag GmbH, Neuss, Germany
[2] Graz Univ, Dept Obstet & Gynecol, Unit Gynecol Endorcrinol & Reprod Med, Graz, Austria
[3] Family Fed Finland, Sexual Hlth Clin, Helsinki, Finland
[4] Univ Cape Town, Groote Schuur Hosp, Cape Town, South Africa
[5] Kingsbury Hosp, Cape Town, South Africa
[6] Sandton Medi Clin, Bryanston, South Africa
[7] Praxis Frauenheilkunde, Rheinstetten, Germany
[8] Hop Lapeyronie, Montpellier, France
[9] OrthoMcNeil Pharmaceut, Raritan, NJ USA
关键词
transdermal contraceptive patch; oral contraceptive; efficacy; safety; compliance; satisfaction;
D O I
10.1016/j.ejogrb.2005.01.021
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To investigate contraceptive efficacy, compliance and user's satisfaction with transdermal versus oral contraception (OC). Study design: Randomized, open-label, parallel-group trial conducted at 65 centers in Europe and South Africa. One thousand four hundred and eighty-nine women received a contraceptive patch (n = 846) or an OC (n = 643) for 6 or 13 cycles. Results: Overall/method-failure Pearl Indices were 0.88/0.66 with the patch and 0.56/0.28 with the OC (p = n.s.). Compliance was higher at all age groups with the patch compared to the OC. Significantly more users were very satisfied with the contraceptive patch than with the OC. The percentage of patch users being very satisfied increased with age whereas it did not in the OC group. Likewise, improvements of premenstrual symptoms as well as emotional and physical well-being increased with age in the patch-group in contrast to the OC group. Ratings of satisfaction with the study medication correlated weakly with emotional (r = 0.33) and physical well-being (r = 0.39) as well as premenstrual symptoms (r = 0.30; p < 0.001). Conclusion: Contraceptive efficacy of the patch is comparable to OC, but compliance is consistently better at all age groups. Higher satisfaction with the patch at increasing age may be attributed to improvements in emotional and physical well-being as well as reduction of premenstrual symptoms. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:202 / 210
页数:9
相关论文
共 24 条
[1]   Pharmacokinetics of a contraceptive patch (Evra™/Ortho Evra™) containing norelgestromin and ethinyloestradiol at four application sites [J].
Abrams, LS ;
Skee, DM ;
Natarajan, J ;
Wong, FA ;
Anderson, GD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (02) :141-146
[2]   Pharmacokinetics of norelgestromin and ethinyl estradiol delivered by a contraceptive patch (Ortho Evra™/Evra™) under conditions of heat, humidity, and exercise [J].
Abrams, LS ;
Skee, DM ;
Natarajan, J ;
Wong, FA ;
Leese, PT ;
Creasy, GW ;
Shangold, MM .
JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (12) :1301-1309
[3]   The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra®) on contraceptive efficacy [J].
Archer, DF ;
Cullins, V ;
Creasy, GW ;
Fisher, AC .
CONTRACEPTION, 2004, 69 (03) :189-195
[4]  
Archer DF, 2002, FERTIL STERIL, V77, pS27
[5]   Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive - A randomized controlled trial [J].
Audet, MC ;
Moreau, M ;
Koltun, WD ;
Waldbaum, AS ;
Shangold, G ;
Fisher, AC ;
Creasy, GW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (18) :2347-2354
[6]  
Backström T, 2003, CNS DRUGS, V17, P325
[7]   Contraception: from accessibility to efficiency [J].
Bajos, N ;
Leridon, H ;
Goulard, H ;
Oustry, P ;
Job-Spira, N .
HUMAN REPRODUCTION, 2003, 18 (05) :994-999
[8]  
Bishop M.M., 1975, DISCRETE MULTIVARIAT
[9]  
*CPMP, 2000, NOT GUID CLIN INV ST
[10]   Compliance with contraceptives and other treatments [J].
Cramer, JA .
OBSTETRICS AND GYNECOLOGY, 1996, 88 (03) :S4-S12